Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (1-10 of 442) with videos related to

Pageof 45
Sort By:
Best Practice & Research. Clinical Haematology|August 23, 2023
Describing and analyzing complex disease history in retrospective studiesAriane Boumendil, Myriam Labopin
Best Practice & Research. Clinical Haematology|August 23, 2023
Preface of special edition "Biostatistics in clinical haematology"Myriam Labopin, Ariane Boumendil
Biostatistics (Oxford, England)|November 3, 2011
Competing risks regression for clustered dataBingqing Zhou, Jason Fine, Aurelien Latouche, et al.
Best Practice & Research. Clinical Haematology|September 15, 2010
Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?Annalisa Ruggeri, Fabio Ciceri, Eliane Gluckman, et al.
Journal of Clinical Epidemiology|February 19, 2013
A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functionsAurelien Latouche, Arthur Allignol, Jan Beyersmann, et al.
Handbook of Clinical Neurology|August 7, 2024
The EBMT-ADWP and the CIBMTRRaffaella Greco, Manuela Badoglio, Myriam Labopin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Prognostic Scoring Systems in Allogeneic Hematopoietic Stem Cell Transplantation: Where Do We Stand?Rashmika Potdar, Gabor Varadi, Joshua Fein, et al.
Haematologica|October 4, 2017
Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMTReinhold Munker, Myriam Labopin, Jordi Esteve, et al.
Haematologica|June 21, 2011
Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow TransplantationPatrice Chevallier, Myriam Labopin, Jan Cornelissen, et al.
Blood Cells, Molecules & Diseases|July 24, 2012
Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complicationsSandra Malak, Myriam Labopin, Cecile Saint-Martin, et al.
Pageof 45

Showing results (1-10 of 442) with videos related to

Sort By:
Pageof 45
Best Practice & Research. Clinical Haematology|August 23, 2023
Describing and analyzing complex disease history in retrospective studiesAriane Boumendil, Myriam Labopin
Best Practice & Research. Clinical Haematology|August 23, 2023
Preface of special edition "Biostatistics in clinical haematology"Myriam Labopin, Ariane Boumendil
Biostatistics (Oxford, England)|November 3, 2011
Competing risks regression for clustered dataBingqing Zhou, Jason Fine, Aurelien Latouche, et al.
Best Practice & Research. Clinical Haematology|September 15, 2010
Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?Annalisa Ruggeri, Fabio Ciceri, Eliane Gluckman, et al.
Journal of Clinical Epidemiology|February 19, 2013
A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functionsAurelien Latouche, Arthur Allignol, Jan Beyersmann, et al.
Handbook of Clinical Neurology|August 7, 2024
The EBMT-ADWP and the CIBMTRRaffaella Greco, Manuela Badoglio, Myriam Labopin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Prognostic Scoring Systems in Allogeneic Hematopoietic Stem Cell Transplantation: Where Do We Stand?Rashmika Potdar, Gabor Varadi, Joshua Fein, et al.
Haematologica|October 4, 2017
Mixed phenotype acute leukemia: outcomes with allogeneic stem cell transplantation. A retrospective study from the Acute Leukemia Working Party of the EBMTReinhold Munker, Myriam Labopin, Jordi Esteve, et al.
Haematologica|June 21, 2011
Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow TransplantationPatrice Chevallier, Myriam Labopin, Jan Cornelissen, et al.
Blood Cells, Molecules & Diseases|July 24, 2012
Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complicationsSandra Malak, Myriam Labopin, Cecile Saint-Martin, et al.
Pageof 45